[4-(6-fluoro-7-methylamino-2,4-dioxo-1, 4-dihydro-2H-quinazolin-3-yl) - phenyl]-5-chloro-thiophen-2-yl-sulfonylu rea salts, forms and methods related thereto

Details for Australian Patent Application No. 2009313565 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Sharp, Emma; Quegan, Louisa Jane; Pandey, Anjali; Wang, Juan; Nieder, Matthew; Huang, Wolin

Agent Davies Collison Cave

Pub. Number AU-A-2009313565

PCT Pub. Number WO2010/054020

Priority 12/265,699 05.11.08 US

Filing date 4 November 2009

Wipo publication date 14 May 2010

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054020 Priority application(s): WO2010/054020

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313582-Glaucoma drainage shunts and methods of use

2009313562-Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta